Logo image of CMBM

CAMBIUM NETWORKS CORP (CMBM) Stock Fundamental Analysis

NASDAQ:CMBM - Nasdaq - KYG177661090 - Common Stock - Currency: USD

0.32  -0.03 (-7.51%)

After market: 0.3155 0 (-1.41%)

Fundamental Rating

3

Taking everything into account, CMBM scores 3 out of 10 in our fundamental rating. CMBM was compared to 50 industry peers in the Communications Equipment industry. While CMBM seems to be doing ok healthwise, there are quite some concerns on its profitability. CMBM has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CMBM had negative earnings in the past year.
CMBM had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CMBM reported negative net income in multiple years.
In multiple years CMBM reported negative operating cash flow during the last 5 years.
CMBM Yearly Net Income VS EBIT VS OCF VS FCFCMBM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M -60M

1.2 Ratios

CMBM has a Return On Assets of -44.08%. This is amonst the worse of the industry: CMBM underperforms 84.00% of its industry peers.
CMBM has a Return On Equity of -224.89%. This is amonst the worse of the industry: CMBM underperforms 84.00% of its industry peers.
Industry RankSector Rank
ROA -44.08%
ROE -224.89%
ROIC N/A
ROA(3y)-3.98%
ROA(5y)-2.62%
ROE(3y)-16.13%
ROE(5y)-12.63%
ROIC(3y)N/A
ROIC(5y)N/A
CMBM Yearly ROA, ROE, ROICCMBM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80

1.3 Margins

CMBM has a worse Gross Margin (17.14%) than 90.00% of its industry peers.
In the last couple of years the Gross Margin of CMBM has declined.
The Profit Margin and Operating Margin are not available for CMBM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y-8.13%
CMBM Yearly Profit, Operating, Gross MarginsCMBM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

CMBM does not have a ROIC to compare to the WACC, probably because it is not profitable.
CMBM has more shares outstanding than it did 1 year ago.
CMBM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CMBM is higher compared to a year ago.
CMBM Yearly Shares OutstandingCMBM Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
CMBM Yearly Total Debt VS Total AssetsCMBM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

CMBM has an Altman-Z score of -1.01. This is a bad value and indicates that CMBM is not financially healthy and even has some risk of bankruptcy.
CMBM has a worse Altman-Z score (-1.01) than 72.00% of its industry peers.
CMBM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.01
ROIC/WACCN/A
WACC8.19%
CMBM Yearly LT Debt VS Equity VS FCFCMBM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

CMBM has a Current Ratio of 1.10. This is a normal value and indicates that CMBM is financially healthy and should not expect problems in meeting its short term obligations.
CMBM's Current ratio of 1.10 is on the low side compared to the rest of the industry. CMBM is outperformed by 78.00% of its industry peers.
CMBM has a Quick Ratio of 1.10. This is a bad value and indicates that CMBM is not financially healthy enough and could expect problems in meeting its short term obligations.
CMBM's Quick ratio of 0.82 is on the low side compared to the rest of the industry. CMBM is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.82
CMBM Yearly Current Assets VS Current LiabilitesCMBM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

CMBM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1047.37%.
The Revenue for CMBM has decreased by -34.89% in the past year. This is quite bad
The Revenue has been decreasing by -1.85% on average over the past years.
EPS 1Y (TTM)-1047.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.18%
Revenue 1Y (TTM)-34.89%
Revenue growth 3Y-7.53%
Revenue growth 5Y-1.85%
Sales Q2Q%1.58%

3.2 Future

The Earnings Per Share is expected to grow by 22.05% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.03% on average over the next years.
EPS Next Y8.93%
EPS Next 2Y43.02%
EPS Next 3Y22.05%
EPS Next 5YN/A
Revenue Next Year-21.05%
Revenue Next 2Y-3.53%
Revenue Next 3Y0.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBM Yearly Revenue VS EstimatesCMBM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CMBM Yearly EPS VS EstimatesCMBM Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CMBM. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 6.27, the valuation of CMBM can be described as very cheap.
CMBM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CMBM is cheaper than 96.00% of the companies in the same industry.
CMBM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
Industry RankSector Rank
PE N/A
Fwd PE 6.27
CMBM Price Earnings VS Forward Price EarningsCMBM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CMBM Per share dataCMBM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CMBM's earnings are expected to grow with 22.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.02%
EPS Next 3Y22.05%

More info and screens

0

5. Dividend

5.1 Amount

CMBM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAMBIUM NETWORKS CORP

NASDAQ:CMBM (6/13/2025, 8:00:01 PM)

After market: 0.3155 0 (-1.41%)

0.32

-0.03 (-7.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)05-29 2025-05-29/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners21.68%
Inst Owner Change1.24%
Ins Owners3.7%
Ins Owner Change-0.22%
Market Cap9.04M
Analysts82.5
Price Target5.1 (1493.75%)
Short Float %12.34%
Short Ratio5.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.63%
Min EPS beat(2)-15.61%
Max EPS beat(2)18.88%
EPS beat(4)1
Avg EPS beat(4)-57.09%
Min EPS beat(4)-139.74%
Max EPS beat(4)18.88%
EPS beat(8)3
Avg EPS beat(8)-82.13%
EPS beat(12)7
Avg EPS beat(12)3.73%
EPS beat(16)11
Avg EPS beat(16)9.26%
Revenue beat(2)0
Avg Revenue beat(2)-3.75%
Min Revenue beat(2)-5.39%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-5.07%
Min Revenue beat(4)-8.54%
Max Revenue beat(4)-2.12%
Revenue beat(8)1
Avg Revenue beat(8)-5.94%
Revenue beat(12)3
Avg Revenue beat(12)-3.54%
Revenue beat(16)6
Avg Revenue beat(16)-2.28%
PT rev (1m)0%
PT rev (3m)25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.27
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB 0.65
EV/EBITDA N/A
EPS(TTM)-1.8
EYN/A
EPS(NY)0.05
Fwd EY15.94%
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS6.1
BVpS1.54
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.08%
ROE -224.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.14%
FCFM N/A
ROA(3y)-3.98%
ROA(5y)-2.62%
ROE(3y)-16.13%
ROE(5y)-12.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y-8.13%
F-Score2
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 128.96%
Cap/Sales 7.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.82
Altman-Z -1.01
F-Score2
WACC8.19%
ROIC/WACCN/A
Cap/Depr(3y)130.65%
Cap/Depr(5y)120.32%
Cap/Sales(3y)3.75%
Cap/Sales(5y)3.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1047.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.18%
EPS Next Y8.93%
EPS Next 2Y43.02%
EPS Next 3Y22.05%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.89%
Revenue growth 3Y-7.53%
Revenue growth 5Y-1.85%
Sales Q2Q%1.58%
Revenue Next Year-21.05%
Revenue Next 2Y-3.53%
Revenue Next 3Y0.03%
Revenue Next 5YN/A
EBIT growth 1Y-733.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-58.16%
EBIT Next 3Y65.62%
EBIT Next 5YN/A
FCF growth 1Y-105.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-595.46%
OCF growth 3YN/A
OCF growth 5YN/A